Forecasting The Future: 14 Analyst Projections For Rhythm Pharmaceuticals
Forecasting The Future: 14 Analyst Projections For Rhythm Pharmaceuticals
預測未來：14位分析師對Rhythm Pharmaceuticals的預測
Ratings for Rhythm Pharmaceuticals (NASDAQ:RYTM) were provided by 14 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 12 | 1 | 1 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 3 | 0 | 0 | 0 | 0 |
| 2M Ago | 8 | 0 | 0 | 0 | 0 |
| 3M Ago | 1 | 0 | 1 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $67.36, a high estimate of $80.00, and a low estimate of $52.00. This upward trend is evident, with the current average reflecting a 6.5% increase from the previous average price target of $63.25.
Investigating Analyst Ratings: An Elaborate Study
A comprehensive examination of how financial...
登入免費觀看全文
登入/註冊